Bank of America
RVMD icon

Bank of America’s Revolution Medicines RVMD Stock Holding History

Bank of America’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-151,600
Closed -$4.2M – 8198
2023
Q3 		$4.2M Buy
+151,600
New +$4.5M ﹤0.01% 3568

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America's RVMD Position: Q1 2026 in Review

Bank of America reduced its Revolution Medicines (RVMD) stake by 30% in Q1 2026, selling an estimated $26.8M and leaving 614,157 shares worth $59.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Bank of America first reported a position in RVMD in Q1 2020 and has held it in 25 quarters since. The position peaked at $70.1M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Bank of America held 614,157 shares of Revolution Medicines worth $59.7M as of Q1 2026.
  • Bank of America sold 265,688 Revolution Medicines shares in Q1 2026, an estimated $26.8M.
  • Revolution Medicines made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1477 holding.
  • Bank of America first reported a position in Revolution Medicines in Q1 2020 and has held it in 25 quarters since.
  • Bank of America's Revolution Medicines position peaked at $70.1M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.